198 related articles for article (PubMed ID: 17712813)
1. On the pharmacological properties of Delta9-tetrahydrocannabinol (THC).
Costa B
Chem Biodivers; 2007 Aug; 4(8):1664-77. PubMed ID: 17712813
[TBL] [Abstract][Full Text] [Related]
2. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
3. Fungal biotransformation of cannabinoids: potential for new effective drugs.
Saxena S
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):305-12. PubMed ID: 19333876
[TBL] [Abstract][Full Text] [Related]
4. [The endocannabinoid system as a target for the development of new drugs for cancer therapy].
Bifulco M; Di Marzo V
Recenti Prog Med; 2003 May; 94(5):194-8. PubMed ID: 12723496
[TBL] [Abstract][Full Text] [Related]
5. [The role of endocannabinoid system in physiological and pathological processes in the eye].
Nadolska K; Goś R
Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptors in atherosclerosis.
Steffens S; Mach F
Curr Opin Lipidol; 2006 Oct; 17(5):519-26. PubMed ID: 16960500
[TBL] [Abstract][Full Text] [Related]
7. Cannabis: pharmacology and toxicology in animals and humans.
Adams IB; Martin BR
Addiction; 1996 Nov; 91(11):1585-614. PubMed ID: 8972919
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids and gastrointestinal motility: animal and human studies.
Aviello G; Romano B; Izzo AA
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():81-93. PubMed ID: 18924447
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
[TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid system and its therapeutic exploitation.
Di Marzo V; Bifulco M; De Petrocellis L
Nat Rev Drug Discov; 2004 Sep; 3(9):771-84. PubMed ID: 15340387
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
Burns TL; Ineck JR
Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
[TBL] [Abstract][Full Text] [Related]
12. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways.
Verhoeckx KC; Korthout HA; van Meeteren-Kreikamp AP; Ehlert KA; Wang M; van der Greef J; Rodenburg RJ; Witkamp RF
Int Immunopharmacol; 2006 Apr; 6(4):656-65. PubMed ID: 16504929
[TBL] [Abstract][Full Text] [Related]
13. The effect of delta 9-tetrahydrocannabinol on the extinction of an adverse associative memory.
Ashton JC; Smith PF; Darlington CL
Pharmacology; 2008; 81(1):18-20. PubMed ID: 17726344
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship of substitutions at the C-1 position of Delta9-tetrahydrocannabinol.
Burdick D; DeOrazio R; Guzzo P; Habershaw A; Helle M; Paul B; Wolf M
Bioorg Med Chem Lett; 2010 Feb; 20(4):1424-6. PubMed ID: 20079638
[TBL] [Abstract][Full Text] [Related]
15. Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation.
Farrimond JA; Mercier MS; Whalley BJ; Williams CM
Phytother Res; 2011 Feb; 25(2):170-88. PubMed ID: 21213357
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
17. The good and the bad effects of (-) trans-delta-9-tetrahydrocannabinol (Delta 9-THC) on humans.
Carlini EA
Toxicon; 2004 Sep; 44(4):461-7. PubMed ID: 15302527
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid transmission and pain perception.
Martin BR; Lichtman AH
Neurobiol Dis; 1998 Dec; 5(6 Pt B):447-61. PubMed ID: 9974177
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
González S; Cebeira M; Fernández-Ruiz J
Pharmacol Biochem Behav; 2005 Jun; 81(2):300-18. PubMed ID: 15919107
[TBL] [Abstract][Full Text] [Related]
20. Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2.
Lewis DY; Brett RR
Eur Neuropsychopharmacol; 2010 Sep; 20(9):622-31. PubMed ID: 20471226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
